Can we harness the microbiota to enhance the efficacy of cancer immunotherapy?

B. Brett Finlay, Romina Goldszmid, Kenya Honda, Giorgio Trinchieri, Jennifer Wargo, Laurence Zitvogel

Research output: Contribution to journalArticle

Abstract

There is currently much interest in defining how the microbiota shapes immune responses in the context of cancer. Various studies in both mice and humans have associated particular commensal species with better (or worse) outcomes in different cancer types and following treatment with cancer immunotherapies. However, the mechanisms involved remain ill-defined and even controversial. In this Viewpoint, Nature Reviews Immunology has invited six eminent scientists in the field to share their thoughts on the key questions and challenges for the field.

Original languageEnglish
Pages (from-to)522-528
Number of pages7
JournalNature Reviews Immunology
Volume20
Issue number9
DOIs
Publication statusPublished - 2020 Sep 1

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Can we harness the microbiota to enhance the efficacy of cancer immunotherapy?'. Together they form a unique fingerprint.

  • Cite this